Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE Interestingly, FTLD-tau cases with MAPT mutations had similar patterns and severity of neuropathological features to sporadic FTLD-tau subtypes and could be classified into: Pick's disease (K257T), corticobasal degeneration (S305S, IVS10‰+‰16, R406W), progressive supranuclear palsy (S305S) or globular glial tauopathy (P301L, IVS10‰+‰16). 29253099 2018
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE Among MAPT mutations, p.P301L is the most frequently associated to different phenotypes: (1) aggressive, symmetrical, and early-onset Parkinsonism; (2) late parkinsonism associated with FTD; and (3) progressive supranuclear palsy but only exceptionally it is reported associated to CBS. 28268100 2017
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE Neuropathological examination confirmed the PSP diagnosis in the first two subjects; the MAPT P301L mutation carrier had an atypical tauopathy characterized by grain-like tau-containing neurites in gray and white matter with heaviest burden in basal ganglia. 27997036 2017
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681 2016
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE We found reduced mRNA and protein expression of FOXP2 in frontal cortex area 8 in Pick's disease, and frontotemporal lobar degeneration-tau linked to P301L mutation presenting with language impairment in comparison with age-matched controls and cases with parkinsonian variant progressive supranuclear palsy. 27497476 2016
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE Gene expression studies of cytokines and mediators of the immune response have been made in post-mortem human brain samples in AD, sPD, sporadic Creutzfeldt-Jakob disease (sCJD) subtypes MM1 and VV2, Pick's disease (PiD), progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration linked to mutation P301L in MAPT Frontotemporal lobar degeneration-tau (FTLD-tau). 26861289 2016
Progressive supranuclear palsy
CUI: C0038868
Disease: Progressive supranuclear palsy
0.070 GeneticVariation BEFREE The present study examined the similarities of tau APFs with other tau amyloid species and showed for the first time the presence of tau APFs in brain tissue from patients with progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB), as well as in the P301L mouse model, which overexpresses mutated tau. 24887264 2014